Join Apeloa at CPHI Frankfurt to Explore Advanced Technology & Integrated Solutions (Booth 9.1B64)

The global pharmaceutical industry gathers this week at CPHI Frankfurt 2025 from October 28–30. As a global leading ...
Stocktwits on MSN

Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform

Collaboration with Monash University to Address a Large Pharmaceutical Opportunity MELBOURNE, Australia, Oct. 23, 2025 (GLOBE ...
TMCnet

Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025

Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of ...

Plant-based Active Pharmaceutical Ingredients Strategic Business Report 2025 | Global Plant-Based API Market to Reach $46.6 Billion by 2030

The plant-based API market is primed for growth due to heightened demand for sustainable, natural therapeutics and regulatory acceptance. Advances in extraction and purification improve reliability ...
Business Wire

Alliance Pharma and Drug Development Solutions Are Now Resolian

MALVERN, Pa.--(BUSINESS WIRE)--Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development ...
News Medical

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has today announced ...
GEN

Drug Development 3D Multi-Omics Solutions

Enhanc3D Genomics has announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery. The new 3D multi-omics offerings were designed to ...
News Medical

Enhanc3D Genomics launches suite of 3D multi-omics solutions to accelerate drug development

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...
TMCnet

Curia Invests $4 Million to Enhance Sterile API Manufacturing

Curia’s global API aseptic processing manufacturing network has served a broad portfolio of customers worldwide for more than 20 years. This investment positions the company to support increasingly ...
GEN

Thermo Fisher-Tufts Study Links CRO-CDMO Platform to Shorter Cancer Drug Development Timeframe

Thermo Fisher Scientific says addressing the need for prefilled syringes is among potential production bottlenecks, the company is working to address. Thermo Fisher’s Accelerator™ Drug Development ...
Nasdaq

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

RADNOR, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Adrian McKemey, Ph.D. as President ...